In situ filling of cage with the Graftgun®. Image courtesy of SurGenTec
SurGenTec was issued U.S. Patent No. 9,668,881 protecting its Graftgun® bone graft loading technology, used to post-fill implant cages. The kit includes a universal loading device that can deliver allograft, autograft or synthetic biologics into bone voids, disc spaces, cages and implants.
Graftgun can be customized for nearly any cage, including expandable designs, without a change of instruments required. Ratcheting technology supplies sufficient and controllable force to extrude materials, ensuring a complete void fill.
This represents the company’s third issued U.S. patent. Global launch of the Graftgun is expected this year.
SurGenTec was issued U.S. Patent No. 9,668,881 protecting its Graftgun® bone graft loading technology, used to post-fill implant cages. The kit includes a universal loading device that can deliver allograft, autograft or synthetic biologics into bone voids, disc spaces, cages and implants.
Graftgun can be customized for nearly any cage,...
In situ filling of cage with the Graftgun®. Image courtesy of SurGenTec
SurGenTec was issued U.S. Patent No. 9,668,881 protecting its Graftgun® bone graft loading technology, used to post-fill implant cages. The kit includes a universal loading device that can deliver allograft, autograft or synthetic biologics into bone voids, disc spaces, cages and implants.
Graftgun can be customized for nearly any cage, including expandable designs, without a change of instruments required. Ratcheting technology supplies sufficient and controllable force to extrude materials, ensuring a complete void fill.
This represents the company’s third issued U.S. patent. Global launch of the Graftgun is expected this year.
Copy to clipboard 
